A Medical Device Daily

Uroplasty (Minnetonka, Minnesota) reported Aetna's national insurance coverage policy for Percutaneous Tibial Nerve Stimulation (PTNS) therapy for the treatment of overactive bladder (OAB) symptoms. Uroplasty says that its Urgent PC Neurostimulation System is the only device available to deliver PTNS.

“Aetna's policy, in combination with prior coverage decisions by Blue Cross Blue Shield of Minnesota, Blue Cross Blue Shield of Maryland, and reimbursement by numerous other payers, significantly expands patient access to PTNS therapy, a non-drug, non-surgical therapy for treatment of OAB symptoms,” said Uroplasty President and CEO Daniel Holman.

Uroplasty, with wholly owned subsidiaries in the Netherlands and the UK, develops products for the treatment of voiding dysfunctions, including urinary and fecal incontinence, overactive bladder and vesicoureteral reflux.